Literature DB >> 30626287

Impact of Stent Retriever Size on Clinical and Angiographic Outcomes in the STRATIS Stroke Thrombectomy Registry.

Osama O Zaidat1, Diogo C Haussen2,3, Ameer E Hassan4, Ashutosh P Jadhav5, Brijesh P Mehta6, Maxim Mokin7, Nils H Mueller-Kronast8, Michael T Froehler9.   

Abstract

Background and Purpose- The safety and efficacy of mechanical thrombectomy in patients with acute ischemic stroke has been demonstrated. However, the impact of stent retriever size on clinical and angiographic outcomes is not well established. Methods- This was a retrospective ad hoc analysis of data from the STRATIS (Systematic Evaluation of Patients Treated With Neurothrombectomy Devices for Acute Ischemic Stroke) registry-a prospective, multicenter study of patients with large vessel occlusion treated with the Solitaire stent retriever. An independent core laboratory, blinded to clinical outcomes, reviewed all procedures and angiographic data to classify stent retriever size, targeted clot location, recanalization after each pass, and the number of stent retriever passes. The primary angiographic end point was first-pass effect (FPE) as determined by a core laboratory and defined as achieving near-complete revascularization (modified Thrombolysis in Cerebral Infarction ≥2c) after the first pass without the use of rescue therapy. Rates of modified FPE were also assessed, defined as meeting all criteria for FPE but achieving modified Thrombolysis in Cerebral Infarction ≥2b after first pass. The primary clinical end point was functional independence (modified Rankin Scale, 0-2) at 3 months as determined on-site. Outcome comparisons were made across the stent retriever size groups and adjusted for baseline characteristics. Results- Of 715 patients, a 4×20 stent retriever was used in 201 (28%) patients, 4×40 was used in 270 (38%) patients, and 6×30 was used in 244 (34%) patients. The 4×40 group had the highest rate of FPE ( P=0.003 versus 6×30) and modified FPE ( P=0.038 versus 4×20; P=0.0001 versus 6×30). Final revascularization was not significantly different across the groups, and there were no significant differences in functional dependence or mortality at 90 days post-procedure. Use of the longer stent retriever (4×40) was an independent predictor of achieving modified FPE ( P=0.037 versus 6×30; P=0.037 versus 4×20). Conclusions- The longer stent retriever (4×40) demonstrated the highest rate FPE and modified FPE compared with larger diameter or shorter stent retrievers, suggesting that their routine use may improve early revascularization success. Clinical Trial Registration- URL: https://www.clinicaltrials.gov . Unique identifier: NCT02239640.

Entities:  

Keywords:  animals; humans; stents; stroke; thrombectomy

Mesh:

Year:  2019        PMID: 30626287     DOI: 10.1161/STROKEAHA.118.022987

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  8 in total

1.  Risks of Undersizing Stent Retriever Length Relative to Thrombus Length in Patients with Acute Ischemic Stroke.

Authors:  N F Belachew; T Dobrocky; T R Meinel; A Hakim; J Vynckier; M Arnold; D J Seiffge; R Wiest; E I Piechowiak; U Fischer; J Gralla; P Mordasini; J Kaesmacher
Journal:  AJNR Am J Neuroradiol       Date:  2021-10-14       Impact factor: 3.825

2.  SOFIA catheter for direct aspiration of large vessel occlusion stroke: A single-center cohort and meta-analysis.

Authors:  Federico Bolognini; Pablo A Lebedinsky; Mariano Musacchio; Mariette Delaitre; Abdoulaye M Traoré; Francis Vuillemet; François Sellal; Jean-François Cerfon; Eric Schluck; Daniela Iancu; Elena A Cora; Sébastien Richard; René Anxionnat; Benjamin Gory; Stephanos N Finitsis
Journal:  Interv Neuroradiol       Date:  2021-04-04       Impact factor: 1.610

3.  Clinical and Procedural Outcomes with or without Balloon Guide Catheters during Endovascular Thrombectomy in Acute Ischemic Stroke: A Systematic Review and Meta-analysis with First-line Technique Subgroup Analysis.

Authors:  A Podlasek; P S Dhillon; G Jewett; A Shahein; M Goyal; M Almekhlafi
Journal:  AJNR Am J Neuroradiol       Date:  2021-05-27       Impact factor: 4.966

4.  Systematic review and meta-analysis of current rates of first pass effect by thrombectomy technique and associations with clinical outcomes.

Authors:  Mehdi Abbasi; Yang Liu; Seán Fitzgerald; Oana Madalina Mereuta; Jorge L Arturo Larco; Asim Rizvi; Ramanathan Kadirvel; Luis Savastano; Waleed Brinjikji; David F Kallmes
Journal:  J Neurointerv Surg       Date:  2021-01-13       Impact factor: 8.572

5.  Predictors and prognoses of Willisian collateral failure during mechanical thrombectomy.

Authors:  Seong-Joon Lee; Yang-Ha Hwang; Ji Man Hong; Jin Wook Choi; Dong-Hun Kang; Yong-Won Kim; Yong-Sun Kim; Jeong-Ho Hong; Joonsang Yoo; Chang-Hyun Kim; Bruce Ovbiagele; Andrew Demchuk; Sung-Il Sohn; Jin Soo Lee
Journal:  Sci Rep       Date:  2020-11-30       Impact factor: 4.379

6.  Economic impact of the first pass effect in mechanical thrombectomy for acute ischaemic stroke treatment in Spain: a cost-effectiveness analysis from the national health system perspective.

Authors:  Eva González Diaz; Carlos Rodríguez-Paz; Andres Fernandez-Prieto; Mario Martínez-Galdámez; Rosa Martínez-Moreno; Joaquín Ortega Quintanilla; Alejandro Tomasello; Joaquín Zamarro; David Liebeskind; Osama O Zaidat; Nils H Mueller-Kronast
Journal:  BMJ Open       Date:  2022-09-01       Impact factor: 3.006

7.  Comparison of First-Pass Effect in Aspiration vs. Stent-Retriever for Acute Intracranial ICA Occlusion.

Authors:  David Hernández; Elena Serrano; Gemma Molins; Federico Zarco; Oscar Chirife; Mariano Werner; Blanca Lara; Anna Ramos; Laura Llull; Manuel Requena; Marta de Dios Las Cuevas; Sebastián Remollo; Carlos Piñana; Antonio López-Rueda
Journal:  Front Neurol       Date:  2022-06-30       Impact factor: 4.086

8.  First-Pass Reperfusion by Mechanical Thrombectomy in Acute M1 Occlusion: The Size of Retriever Matters.

Authors:  Carmen Serna Candel; Marta Aguilar Pérez; Hansjörg Bäzner; Hans Henkes; Victoria Hellstern
Journal:  Front Neurol       Date:  2021-06-22       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.